These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mutagenicity testing in mammalian cells. I. Derivation of a Chinese hamster ovary cell line heterozygous for the adenine phosphoribosyltransferase and thymidine kinase loci. Adair GM, Carver JH, Wandres DL. Mutat Res; 1980 Sep; 72(2):187-205. PubMed ID: 6449663 [Abstract] [Full Text] [Related]
4. Mutagenic responses of five independent genetic loci in CHO cells to a variety of mutagens. Development and characteristics of a mutagen screening system based on selection for multiple drug-resistant markers. Gupta RS, Singh B. Mutat Res; 1982 Jun; 94(2):449-66. PubMed ID: 7110183 [Abstract] [Full Text] [Related]
5. Studies on the activities of benzo[a]pyrene, benzidine and ethyl methanesulphonate in the L5178Y TK +/- mouse lymphoma mutagenicity assay using standardized and non-standardized protocols. Riach CG, Cattanach PJ, Howgate S, Shepherd W, McBride D, Edwards IW, McGregor DB, Combes RD. Mutagenesis; 1990 Jun; 5 Suppl():35-44. PubMed ID: 2184319 [Abstract] [Full Text] [Related]
6. Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci. Moore MM, Harrington-Brock K, Doerr CL, Dearfield KL. Mutagenesis; 1989 Sep; 4(5):394-403. PubMed ID: 2687635 [Abstract] [Full Text] [Related]
7. Induction of 6-thioguanine-resistant mutations by rat-liver homogenate (S9)-activated promutagens in human embryonic skin fibroblasts. Chen DJ, Okinaka RT, Strniste GF, Barnhart BJ. Mutat Res; 1982 Mar; 101(1):87-98. PubMed ID: 7078562 [Abstract] [Full Text] [Related]
8. Effect of metabolic activation on the cytotoxicity and mutagenicity of 1,2-dibromoethane in the CHO/HGPRT system. Brimer PA, Tan EL, Hsie AW. Mutat Res; 1982 Aug; 95(2-3):377-88. PubMed ID: 6750385 [Abstract] [Full Text] [Related]
11. Simplification of the CHO/HGPRT mutation assay through the growth of Chinese hamster ovary cells as unattached cultures. Li AP. Mutat Res; 1981 Jun; 85(3):165-75. PubMed ID: 7196496 [Abstract] [Full Text] [Related]
16. Cytotoxicity and mutagenicity of alkylating agents in cultured mammalian cells (CHO/HGPRT system): mutagen treatment in the presence or absence of serum. O'Neill JP, Schenley RL, Hsie AW. Mutat Res; 1979 Dec; 63(2):381-5. PubMed ID: 522878 [Abstract] [Full Text] [Related]
18. A procedure for the CHO/HGPRT mutation assay involving treatment of cells in suspension culture and selection of mutants in soft-agar. Oberly TJ, Bewsey BJ, Probst GS. Mutat Res; 1987 Apr; 182(2):99-111. PubMed ID: 3561430 [Abstract] [Full Text] [Related]
19. Chinese hamster ovary cells cultured in low concentrations of fetal bovine serum: cloning efficiency, growth in suspension, and selection of drug-resistant mutant phenotypes. Carver JH, Salazar EP, Knize MG. In Vitro; 1983 Sep; 19(9):699-706. PubMed ID: 6618513 [Abstract] [Full Text] [Related]
20. The aprt heterozygote/hemizygote system for screening mutagenic agents allows detection of large deletions. Bradley WE, Belouchi A, Messing K. Mutat Res; 1988 May; 199(1):131-8. PubMed ID: 3362154 [Abstract] [Full Text] [Related] Page: [Next] [New Search]